BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 21177839)

  • 21. Early therapy improves outcomes of exacerbations of chronic obstructive pulmonary disease.
    Wilkinson TM; Donaldson GC; Hurst JR; Seemungal TA; Wedzicha JA
    Am J Respir Crit Care Med; 2004 Jun; 169(12):1298-303. PubMed ID: 14990395
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Responsiveness of the cough and sputum assessment questionnaire in exacerbations of COPD and chronic bronchitis.
    Monz BU; Sachs P; McDonald J; Crawford B; Nivens MC; Tetzlaff K
    Respir Med; 2010 Apr; 104(4):534-41. PubMed ID: 19917525
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Use of plasma biomarkers at exacerbation of chronic obstructive pulmonary disease.
    Hurst JR; Donaldson GC; Perera WR; Wilkinson TM; Bilello JA; Hagan GW; Vessey RS; Wedzicha JA
    Am J Respir Crit Care Med; 2006 Oct; 174(8):867-74. PubMed ID: 16799074
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Mortality-related factors after hospitalization for acute exacerbation of chronic obstructive pulmonary disease: the burden of clinical features.
    Bustamante-Fermosel A; De Miguel-Yanes JM; Duffort-Falcó M; Muñoz J
    Am J Emerg Med; 2007 Jun; 25(5):515-22. PubMed ID: 17543654
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Development of a COPD severity score.
    Wu EQ; Birnbaum HG; Cifaldi M; Kang Y; Mallet D; Colice G
    Curr Med Res Opin; 2006 Sep; 22(9):1679-87. PubMed ID: 16968571
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Community care assessment of exacerbations of chronic obstructive pulmonary disease.
    Hutchinson AF; Thompson MA; Brand CA; Black J; Anderson GP; Irving LB
    J Adv Nurs; 2010 Nov; 66(11):2490-9. PubMed ID: 21039775
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Infections and airway inflammation in chronic obstructive pulmonary disease severe exacerbations.
    Papi A; Bellettato CM; Braccioni F; Romagnoli M; Casolari P; Caramori G; Fabbri LM; Johnston SL
    Am J Respir Crit Care Med; 2006 May; 173(10):1114-21. PubMed ID: 16484677
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Quantifying of severity of exacerbations in chronic obstructive pulmonary disease: adaptations to the definition to allow quantification.
    Jones P; Higenbottam T
    Proc Am Thorac Soc; 2007 Dec; 4(8):597-601. PubMed ID: 18073389
    [TBL] [Abstract][Full Text] [Related]  

  • 29. C-reactive protein and copeptin: prognostic predictors in chronic obstructive pulmonary disease exacerbations.
    Antonescu-Turcu AL; Tomic R
    Curr Opin Pulm Med; 2009 Mar; 15(2):120-5. PubMed ID: 19532026
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Exacerbations and lung function decline in COPD: new insights in current and ex-smokers.
    Makris D; Moschandreas J; Damianaki A; Ntaoukakis E; Siafakas NM; Milic Emili J; Tzanakis N
    Respir Med; 2007 Jun; 101(6):1305-12. PubMed ID: 17112715
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Similarities and differences in asthma and chronic obstructive pulmonary disease exacerbations.
    Pauwels RA
    Proc Am Thorac Soc; 2004; 1(2):73-6. PubMed ID: 16113416
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Inspiratory capacity and forced expiratory volume in the first second in exacerbation of chronic obstructive pulmonary disease.
    Yetkin O; Gunen H
    Clin Respir J; 2008 Jan; 2(1):36-40. PubMed ID: 20298302
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The effect of influenza vaccination on the incidence of chronic obstructive pulmonary disease exacerbations in the immediate postvaccination period.
    Ting SC; Crooks SW; South G
    J Epidemiol Community Health; 2011 Feb; 65(2):157-9. PubMed ID: 19996358
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Etiology and biomarkers of systemic inflammation in mild to moderate COPD exacerbations].
    Saldías PF; Díaz PO; Dreyse DJ; Gaggero BA; Sandoval AC; Lisboa BC
    Rev Med Chil; 2012 Jan; 140(1):10-8. PubMed ID: 22552550
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Early versus late pulmonary rehabilitation in chronic obstructive pulmonary disease patients with acute exacerbations: a randomized trial.
    Puhan MA; Spaar A; Frey M; Turk A; Brändli O; Ritscher D; Achermann E; Kaelin R; Karrer W
    Respiration; 2012; 83(6):499-506. PubMed ID: 21846962
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Impact of gastro-oesophageal reflux disease symptoms on COPD exacerbation.
    Terada K; Muro S; Sato S; Ohara T; Haruna A; Marumo S; Kinose D; Ogawa E; Hoshino Y; Niimi A; Terada T; Mishima M
    Thorax; 2008 Nov; 63(11):951-5. PubMed ID: 18535116
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Case fatality of COPD exacerbations: a meta-analysis and statistical modelling approach.
    Hoogendoorn M; Hoogenveen RT; Rutten-van Mölken MP; Vestbo J; Feenstra TL
    Eur Respir J; 2011 Mar; 37(3):508-15. PubMed ID: 20595157
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Gender differences in emergency department patients with chronic obstructive pulmonary disease exacerbation.
    Cydulka RK; Rowe BH; Clark S; Emerman CL; Rimm AR; Camargo CA
    Acad Emerg Med; 2005 Dec; 12(12):1173-9. PubMed ID: 16282511
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Developing and applying a stochastic dynamic population model for chronic obstructive pulmonary disease.
    Hoogendoorn M; Rutten-van Mölken MP; Hoogenveen RT; Al MJ; Feenstra TL
    Value Health; 2011 Dec; 14(8):1039-47. PubMed ID: 22152172
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Leptin and TNF-alpha levels in patients with chronic obstructive pulmonary disease and their relationship to nutritional parameters.
    Calikoglu M; Sahin G; Unlu A; Ozturk C; Tamer L; Ercan B; Kanik A; Atik U
    Respiration; 2004; 71(1):45-50. PubMed ID: 14872110
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.